Does TREPROSTINIL Cause Hypervolaemia? 580 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 580 reports of Hypervolaemia have been filed in association with TREPROSTINIL (TYVASO). This represents 0.6% of all adverse event reports for TREPROSTINIL.
580
Reports of Hypervolaemia with TREPROSTINIL
0.6%
of all TREPROSTINIL reports
61
Deaths
538
Hospitalizations
How Dangerous Is Hypervolaemia From TREPROSTINIL?
Of the 580 reports, 61 (10.5%) resulted in death, 538 (92.8%) required hospitalization, and 24 (4.1%) were considered life-threatening.
Is Hypervolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 580 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Hypervolaemia?
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (428)
AMBRISENTAN (205)
MACITENTAN (202)
FUROSEMIDE (139)
AMLODIPINE (122)
CYCLOPHOSPHAMIDE (118)
SACUBITRIL\VALSARTAN (115)
TACROLIMUS (100)
PREDNISONE (98)
MYCOPHENOLATE MOFETIL (89)
Which TREPROSTINIL Alternatives Have Lower Hypervolaemia Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE